Enterprise Value
$24.98B$209.35M-0.83%
Summary
- Current Value
- As of today, RPRX enterprise value is $24.98B, down -0.83% on
- All-time High
- RPRX enterprise value is currently -2.78% below its historical high of $25.69B set on
- 1-Year High
- RPRX enterprise value reached a 1-year high of $25.69B on
- 1-Year Low
- RPRX enterprise value reached a 1-year low of $19.65B on
- 1-Year Change
- RPRX enterprise value is up +22.83% over the past 365 days
- Sector rank
- RPRX enterprise value is higher than 95.19% of companies in Healthcare sector
Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Enterprise Value | $24.98B | -0.8% | +2.1% | +6.2% | +1.9% | +22.8% | +9.4% | +4.4% | |
| Price | $39.72 | -1.2% | +3.1% | +9.8% | +2.8% | +29.2% | +0.9% | -23.5% | |
| PE Ratio | 22.71 | -1.2% | +3.1% | +9.8% | +2.8% | +41.7% | -93.5% | +14.9% | |
| TTM Revenue | $2.35B | +1.9% | – | +1.9% | – | +3.7% | +4.6% | +17.1% | |
| TTM EPS | $1.75 | -23.9% | – | -23.9% | – | -31.6% | +50.7% | -71.2% | |
| Market Cap | $17B | -1.2% | +3.1% | +9.3% | +2.8% | +23.8% | -2.7% | -15.8% | |
| Quarterly Total Debt | $8.96B | +11.8% | – | +11.8% | – | +17.8% | +26.0% | +54.2% | |
| Quarterly Cash & Cash Equivalents | $955.04M | +48.0% | – | +48.0% | – | -4.4% | -38.0% | -56.1% | |
| EV/EBITDA | 16.29 | -0.8% | +2.1% | +6.2% | +1.9% | +24.6% | -69.8% | +28.2% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $25.69B | -2.8% | |
| 3M | $25.69B | -2.8% | |
| 6M | $25.69B | -2.8% | |
| 1Y | $25.69B | -2.8% | |
| 3Y | $25.69B | -2.8% | |
| 5Y | $25.69B | -2.8% | |
| All | $25.69B | -2.8% |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $24.38B | +2.5% | |
| 3M | $23.53B | +6.2% | |
| 6M | $22.46B | +11.2% | |
| 1Y | $19.65B | +27.1% | |
| 3Y | $16.74B | +49.2% | |
| 5Y | $16.74B | +49.2% | |
| All | $16.74B | +49.2% |
History
| Date | Value | Change |
|---|---|---|
| $24.98B | +1.9% | |
| $24.52B | +36.2% | |
| $18.00B | -1.0% | |
| $18.19B | -20.6% |
| Date | Value | Change |
|---|---|---|
| $22.89B | +3.3% | |
| $22.16B | -4.4% | |
| $23.18B | - |
FAQ
What is the current enterprise value of RPRX?
As of today, RPRX enterprise value is $24.98B
What is RPRX enterprise value 1-year high?
RPRX enterprise value reached a 1-year high of $25.69B on January 7, 2026
What is RPRX enterprise value 1-year low?
RPRX enterprise value reached a 1-year low of $19.65B on April 8, 2025
What is 1-year change in RPRX enterprise value?
RPRX enterprise value is up +22.83% year-over-year
What is 3-year change in RPRX enterprise value?
RPRX enterprise value is up +9.42% over the past 3 years
How far is RPRX enterprise value from its all-time high?
RPRX enterprise value is currently -2.78% below its historical high of $25.69B set on January 7, 2026
How does RPRX enterprise value rank versus sector peers?
RPRX enterprise value is higher than 95.19% of companies in Healthcare sector
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt −
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx